San Diego Biomedical Research Institute

Audits
3
Findings
36
Total Expended
$18.82M
Latest Accepted
2025-01-17
Location: San Diego, CA
UEI: ZM3DYHAGMKM3 EIN: 463481092

SAM.gov Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
Christine Auciello Manager of Grants & Contracts Auditee
Latonya Knox Partner Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
338662 2024 2025-01-17 Leaf & Cole LLP $7.51M
299658 2023 2024-03-28 Leaf & Cole LLP $6.04M
22031 2022 2023-02-13 Leaf & Cole LLP $5.27M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
338662 2024 2025-01-17 1096023 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096022 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096021 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096020 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096019 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096018 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096017 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096016 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096015 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096014 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096013 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096012 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096011 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096010 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096009 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096008 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096007 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 1096006 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519581 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519580 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519579 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519578 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519577 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519576 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519575 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519574 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519573 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519572 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519571 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519570 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519569 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519568 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519567 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519566 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519565 2024-001 Significant Deficiency - C
338662 2024 2025-01-17 519564 2024-001 Significant Deficiency - C